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Previous research has shown that gold nanoparticles can increase
the effectiveness of radiation on cancer cells. Improved radiation
effectiveness would allow lower radiation doses given to patients,
reducing adverse effects; alternatively, it would provide more
cancer killing at current radiation doses. Damage from radiation
and gold nanoparticles depends in part on the Auger effect, which
is very localized; thus, it is important to place the gold nanoparticles
on or in the cancer cells. In this work, we use the pH-sensitive,
tumor-targeting agent, pH Low-Insertion Peptide (pHLIP), to tether
1.4-nm gold nanoparticles to cancer cells. We find that the conjuga-
tion of pHLIP to gold nanoparticles increases gold uptake in cells
compared with gold nanoparticles without pHLIP, with the nano-
particles distributed mostly on the cellular membranes. We further
find that gold nanoparticles conjugated to pHLIP produce a statis-
tically significant decrease in cell survival with radiation compared
with cells without gold nanoparticles and cells with gold alone. In
the context of our previous findings demonstrating efficient pHLIP-
mediated delivery of gold nanoparticles to tumors, the obtained
results serve as a foundation for further preclinical evaluation of
dose enhancement.
tumor | acidity | targeting | gold nanoparticles | radiation
Gold is an inert and generally nontoxic material with uniqueproperties suitable for many applications such as cancer
diagnosis and treatment (1–7). Nanometer-size gold particles
have recently been shown to increase radiation damage to tu-
mors (2, 8–11). With enhanced radiation, the same level of tu-
mor killing can be had with less radiation exposure for a patient,
reducing the adverse effects of radiation treatments. Similarly,
more tumor killing can be had while using the same levels of
radiation that are currently given.
The increase in radiation effectiveness with gold nanoparticles
is largely a result of two causes. First, gold is capable of ab-
sorbing radiation at a significantly higher rate than tissue: up to
about 100 times more for keV energies (2). Second, gold nano-
particles that interact with radiation can release extra electrons
via the Auger effect. The Auger effect occurs when an atom
releases electrons postionization. Multiple electrons, called
Auger electrons, can be released per ionization. The Auger elec-
trons usually have low enough energy that their effect is localized to
the area surrounding the gold nanoparticles; see, for example, figure
1 in ref. 11. Thus, it is very important to effectively deliver gold
nanoparticles to cancer cells in tumors and to locate them near
DNA or other vital cellular structures and components.
Specific delivery can be accomplished by conjugating gold (or
other nanoparticles) to antibodies or ligands that target over-
expressed proteins on cancer cell surfaces; this approach has
been actively explored for many years for the delivery of small
molecules. However, several recent studies have raised serious
questions about the efficacy of targeting ligands on nanoparticle
accumulation in tumor tissues. Multiple reports have shown
that targeted nanoparticles did not lead to increased tumor
accumulation over nontargeted controls, although increased
cellular uptake was observed in each case (12–14). In addition,
histologic studies showed that antibodies conjugated with gold
nanoparticles do not penetrate deeply into tumors, but mostly
stain peripheral tumor regions (15). The direct injection of
micrometer-sized gold particles does not lead to tumor targeting,
as particles stayed only at the injection site and were not able to
diffuse even within a tumor, hindering tumor coverage (16).
Our approach is based on the targeting of tumor acidity, which
correlates with tumor malignancy (17–19). The pH-sensitive
targeting agents we are developing are based on the action of a
family of pHLIPs (pH Low-Insertion Peptides), which can
“sense” acidity at the surface of cancer cells and deliver di-
agnostic and therapeutic molecules to tumors of different origins
(20–25). It was shown that pHLIP can promote fusion of lipo-
somes with cancer cells and cellular delivery of various payloads
(26, 27), including small gold nanoparticles (26). Recently,
pHLIP was successfully used for the targeting of various nano-
particles to tumors and other acidic diseased tissue (28–31).
pHLIP has also been used to mediate pH-controlled delivery
of both 13-nm water-soluble gold nanoparticles coated with
luminescent europium into human platelets in vitro (32) and
1.4-nm gold nanoparticles to tumors (33). Intratumoral and i.v.
administrations of both demonstrated a significant enhancement
of tumor uptake of 1.4-nm gold nanoparticles conjugated with
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pHLIP. Statistically significant reduction of gold accumulation
was observed in acidic tumors and kidney when pH-nonsensitive
K-pHLIP was used as a vehicle, suggesting an important role of
pH in the pHLIP-mediated targeting of gold nanoparticles.
In this work, we made another important step toward clinical
application of 1.4-nm gold nanoparticles conjugated with pHLIP.
We show that pHLIP can deliver gold to cellular components
in a pH-dependent manner and can enhance radiation damage
in cells.
Results
In this work we used 1.4-nm-diameter gold clusters functionalized
with maleimide. Maleimide-gold clusters were conjugated with
WT-pHLIP containing a single Cys residue at the N terminus:
ACEQNPIYWARYADWLFTTPLLLLDLALLVDADET
After conjugation, the construct was purified, lyophilized,
redissolved in DMSO, quantified, and used in experiments with
cells. As a control (gold alone), we used nonfunctionalized
1.4-nm gold clusters.
Cellular Uptake and Distribution of Gold.We investigated uptake of
gold nanoparticles at normal and low pHs (pH 7.4 and 6.0, re-
spectively), with and without pHLIP on human lung carcinoma
(A549 cells). At pH 6.0, pHLIP was found to increase cellular
uptake of gold nanoparticles by 34% compared with gold nano-
particles alone (P value = 0.023) (Fig. 1 and SI Appendix, Table S1).
The uptake of gold-pHLIP at pH 6.0 increased by 53% compared
with the uptake at pH 7.4 (P value = 0.008). The uptake of
gold alone was also enhanced at pH 6.0 compared with pH 7.4
(P value = 0.014). The uptake of gold-pHLIP was ∼60% of the
treated dose (1.8 μg), which was about 1.1 μg gold. Because
each treatment had ∼1 million cells, the amount of gold per
cell was ∼1.1 × 10−6 μg.
Light microscopy was used to establish the distribution of gold
nanoparticles in cells. Bright field images of cells treated with
gold-pHLIP or gold alone and enhanced with silver are shown in
Fig. 2. The cellular uptake of gold-pHLIP is higher compared
with the uptake of gold alone (Fig. 2 A and B; the images are
taken using a 20× objective). The representative bright field
image of a cell treated with gold-pHLIP and enhanced with silver
obtained at high magnification is shown in Fig. 2C (the image is
taken using a 100× objective). The overlay of fluorescent images
of nuclear stained with DAPI (blue) and cellular membrane
stained with HQ Silver deposited on the gold-nanoparticles (red)
are shown in Fig. 2D. The targeting of the plasma membrane by
gold-pHLIP is clearly seen on all images. We also observed some
staining of internal organelles and nuclei membranes. Targeting
of mitochondria and nuclear membranes was observed in ex-
periments with pHLIP-coated liposomes containing lipids con-
jugated with fluorescent dyes and gold nanoparticles (26).
Clonogenic Assay. Clonogenic assay experiments were performed
to assess cell survival after treatment of cells with gold or gold-
pHLIP and radiation of treated and nontreated cells. The results
of the experiments are summarized in Fig. 3 and SI Appendix,
Tables S2–S5.
We tested 0, 1.5, and 3 Gray of radiation. Gold nanoparticles
alone or conjugated with pHLIP were not toxic for cells in the
absence of radiation. For 1.5 Gray of radiation, we observed a
statistically significant 24% decrease in survival for cells treated
with gold-pHLIP at low pH compared with cells treated with no
gold. We also observed a statistically significant 21% decrease in
survival for cells treated with gold-pHLIP at low pH compared
with cells treated with gold alone. The effect of gold was not
significant at 3 Gray of radiation, likely because the survival of
cells at 3 Gray was low.
Two different methodologies were used: excess gold or gold-
pHLIP was removed after treatment with cells before radiation,
or excess gold and gold-pHLIP was not removed (nonremoval
corresponds with the values shown in red in SI Appendix, Tables
S2–S5). The clonogenic assay results in Fig. 3A include data
obtained at both different methodologies. Fig. 3B shows the data
obtained in the experiments when gold constructs were not re-
moved before radiation. Surprisingly, overall, the nonremoval
data have better survival than the removal data; perhaps this is a
result of the removal process stressing the cells.
We assessed statistical significance for data obtained at 1.5
Gray of radiation by performing an ANOVA, summarized in
Table 1 and SI Appendix, Table S6. When determining the
P values between different gold treatments, we accounted for
the difference in methodology as an additional variable in the
analysis of variance (see Methods for more details). Our data
clearly indicate that cell treatment with gold-pHLIP results in a
statistically significant decrease in cell survival compared with a
treatment with no gold (P value = 3.6 × 10−5) or gold alone
(P value = 0.015).
In a separate experiment, cells were treated with gold con-
structs at pH 7.4, where pHLIP is less effective at inserting into
the cellular membranes. Only small and statistically insignificant
differences in survival between nontreated and treated cells were
seen; the data are given in SI Appendix, Tables S2, S3, and S5.
Discussion
The treatment of cancer involves a trade-off between killing all
cancer cells and affecting healthy tissue and organs as little as
possible. To reduce adverse effects and enhance lethal effects of
radiation for cancer cells, the approaches of binary therapy were
introduced. Binary radiation therapy targets cells at the bi-
ological level with a noncytotoxic agent that is “activated” by
low-energy radiation, thereby destroying cancer cells wherever
they may reside, while sparing normal cells in proximity to the
diseased cells. A number of binary radiation therapies have been
and are being explored (9, 34–36); one of the more promising
approaches is based on dose enhancement through Auger elec-
tron emission secondary to the photoelectric effect dominant at
low photon energies. Auger electron emission generates a cas-
cade of low-energy electrons that travel very short distances and
deposit their energy locally. The number of Auger electrons
generated in targeted cells can be increased significantly by in-
troducing material of a high atomic number (high-Z) into the
target as long as the radiation energy is at or near the K, L, or M
Fig. 1. Cellular uptake of gold. Values are averaged from normalized
readings on a mass spectrometer, as detailed in Methods. All measurements
are given in SI Appendix, Table S1. Data are normalized to gold alone at pH 7.4.
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electron shell binding energies for the material. High-Z nano-
particles made of iodine, gadolinium, or gold are predicted to
produce a clinically achievable dose enhancement of as much as
10-fold. Because low-energy electrons travel very short distances,
it is crucial to deliver and accumulate high-Z material on or in
cancer cells in tumors.
Our strategy is to deliver gold, which is an inert, high-Z ma-
terial widely used in medicine, to cancer cells for the enhance-
ment of radiation effects. The delivery approach we propose is
based on the energy of membrane-associated folding of peptides
from the pHLIP family to target cellular membranes in a pH-
dependent manner (22, 24, 37). At pH < 7.0, pHLIPs insert into
the lipid bilayer of the membrane, which is accompanied by a
coil–helix transition and formation of a transmembrane helix. It
has been shown that pHLIP delivery agents can target acidic
tumors with high accuracy and deliver nanoparticles, including
gold, to cancer cells in tumors (33). In this work, we show the
effect of gold-pHLIP on radiation-induced cell death.
The dose enhancement depends strongly on the photon en-
ergies used for irradiation, as well as on the location and the size
of gold nanoparticles. Regarding the photon energy, the ratio of
gold absorption to human absorption is highest between ∼10 and
100 keV, with the ratio reaching approximately as high as 100
(2). We used 250 kVp X-rays with Sn-Thoraeus filtering to use
the high relative absorption by gold while also accounting for the
fact that lower-energy photons will be absorbed at too small of a
depth to be useful. Regarding the location, it is very important to
deliver gold nanoparticles as close as possible to cancer cells,
as the dose deposited by Auger electrons increases as distance
from the gold nanoparticles decreases (11). We used pHLIP to
locate the gold nanoparticles to cancer cells. Regarding the
nanoparticle size, it is best to use as small a gold nanoparticle
size as possible to minimize the energy deposited inside the gold
by Auger electrons. Simulations by McMahon et al. (11) predict
an increase in relative biological effectiveness for decreasing sizes of
gold nanoparticles. We used 1.4-nm-diameter gold nanoparticles.
The results of our present study indicate that pHLIP causes
cells to take up more 1.4-nm gold nanoparticles than cells
without pHLIP. The gold nanoparticles deposited by pHLIP
mostly accumulate on the plasma membrane. As a result, gold
nanoparticles delivered to cells by pHLIP can enhance radiation-
induced decreases in cell survival. Gold nanoparticles tethered
to the lipid bilayer of the plasma membrane by pHLIP may
trigger cell death by inducing oxidation of lipids, cholesterol, and
membrane proteins. The oxidized lipids are known to modify
membrane physical properties, such as thickness, permeability,
level of hydration and polarity, lipid transbilayer diffusion, loss of
lipid asymmetry, and phase segregation, which results in apo-
ptosis (38, 39). The exposure of phosphatidylserine lipids to the
outer leaflet of the lipid bilayer, promoted by lipid oxidation,
serves as a recognition signal for macrophages to phagocytose
the apoptotic cell (40).
The combination of the clonogenic and uptake results suggests
that pHLIP is able to enhance radiation-induced death by tar-
geting cancer cells and increasing gold uptake. This is particu-
larly important for future preclinical testing. Experiments on
cultured cells reflect steady-state conditions, when constructs are
exposed to cancer cells during the time of incubation. However,
in vivo studies reflect kinetic conditions, when blood flow is high
and constructs have a limited time to reach cancer cells and
accumulate there. Our previous in vivo studies indicate that
pHLIP targeting of 1.4-nm gold nanoparticles to tumors was 11
and 6 times higher compared with tumor targeting by gold alone
(when administrated intratumorally and intravenously, respectively)
(33). Thus, in an upcoming experiment on mice, we expect to ob-
serve more significant enhancement of radiation-induced cancer
killing compared with data obtained on cells. This might open a
new avenue for the treatment of acidic, highly metastatic tumors
in humans.
Methods
Materials.Materials include nonfunctionalized nanogold (from Nanoprobes),
monomaleimido nanogold (from Nanoprobes), Cys-pHLIP (synthesized and
purified by CS Bio), Tris-(2-carboxyethyl) phosphine, hydrochloride (from Life
Technologies), Dulbecco’s modified Eagle’s medium (from Sigma Aldrich),
glutaraldehyde [25% (wt/wt) in water; from Sigma Aldrich], crystal violet (from
Sigma Aldrich), Synaptophysin (from Molecular Probes by Life Technologies),
Fig. 2. Gold distribution in cells. The bright field (A–C) and fluorescence (D) images of cells treated with gold (A) and gold-pHLIP (B–D), followed by washing,
fixation, and enhancement with HQ Silver, are shown at different magnifications (the bar on each image shows a 10-μm scale). The overlay of fluorescent
images of nuclear stained with DAPI (blue) and cellular membrane stained with HQ Silver (red) are shown on D.
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DAPI (from Sigma Aldrich), and Silver enhancement reagent (from Nanoprobes).
Cell type was human lung carcinoma A549 cells (from American Type
Culture Collection).
Preparation of Gold (Gold Alone), Gold Conjugated to pHLIP (Gold-pHLIP). Gold
nanoparticles were cluster gold, 1.4 nm in diameter, from Nanoprobes, Inc.
Monomaleimido nanogold was conjugated to Cys-pHLIP in 40mMphosphate
buffer containing 300mMNaCl at pH 6.5. A reducing agent, Tris-(2-carboxyethyl)
phosphine, was added into the reaction mixture (10× excess compared with
pHLIP) to reduce pHLIP-S-S-pHLIP dimers and promote reaction with gold-
malemide. The reaction vial was incubated overnight at room temperature
on shaker. The next day, the gold-pHLIP conjugates were purified using
Amicon Ultra (10 K) centrifugal filters according to company-recommended
protocol. The product was then lyophilized and redissolved in DMSO. The
concentration of peptide and nanogold was determined by absorbance at
280 nm (e = 13,940 M−1·cm−1) and 420 nm (e = 155,000 M−1·cm−1), re-
spectively. Nonfunctionalized gold (gold alone) was dissolved in DMSO and
quantified using absorbance of gold at 420 nm.
Cellular Uptake of Gold. Approximately 1 million cells A549 were treated with
0.3 μM of either gold alone or gold-pHLIP in cell suspension in serum-free
DMEM at pH 6.0 and 7.4 for 1 h. One nanogold particle (1.4 nm in diameter)
contains, on average, 60 gold atoms, and 0.3 μM particles in 0.5 mL solution
correspond to 1.8 μg of gold. After 1 h of treatment, the cells were pelleted
using centrifugation (2,000 rpm × g for 5 min), followed by removal of
treatment and washing cells with PBS three times. The cells were then dis-
solved in concentrated nitric acid, followed by sonication for about 2 h.
Concentrated solution samples were diluted to give 2% (wt/vol) nitric acid and
analyzed via inductively coupled plasma mass spectroscopy (Thermo-Scientific ×7
series) against calibration standards (IMS 103; UltraScientific).
Cellular Distribution of Gold. About 20,000 A549 cells were seeded on colla-
gen-coated glass-bottom dishes (MatTek) in 200 μL volume. The next day,
cells were treated for 1 h with gold and gold-pHLIP at 0.5 μM concentration
at pH 6.0 in DMEM with no FBS. After treatment, the cells were washed
3 times with PBS, followed by fixation in 4% (wt/vol) formaldehyde for 20 min.
The cells were permeabilized with 0.3% Triton ×100 for 5 min, followed by
washing with PBS and deionized water. Next, the cells were developed with
freshly prepared HQ Silver reagent (Nanoprobes) for about 20 min, followed by
washing with deionized water. Finally, the cells were stained with 5 μMDAPI in
PBS for 5 min, followed by washing with deionized water. The cells were im-
aged using light microscope in a bright field regime to visualize gold enhanced
by silver, and in the fluorescent regime to monitor DAPI and silver fluorescence,
using cut-off filters (ex:em 360 nm/460 nm and ex:em 542 nm/620 nm, respectively).
Irradiation of Cells. Irradiation was performed using a Philips RT 250 X-ray
machine at settings of 250 kVp and 15 mA. A 0.4-mm Sn-Thoraeus Filter was
used. The half-value thickness for this setup is listed as 2.8 mm Cu. The dose
rate was ∼1.5 Gray/minute for each irradiation. Calibration readings were
performed before each measurement, using a Radcal 2026C dosimeter, and
the reading was corrected for differences in temperature and pressure from
standard temperature and pressure. The irradiation dose varied by ∼7%
between the center of the cell dish and the rightmost well in the irradiation
plate that we used (there was ∼1–2% variation in the leftmost well); the
rightmost well was only used in experiments 7–11, and there were always at
least three wells used per treatment.
Clonogenic Assay. The day before irradiation, 25,000 A549 cells per well were
seeded in 48-well plates. One plate with different treatment conditions was
used for each radiation dose. The next day, the cells were treated with no
gold, gold alone, or gold-pHLIP at 8 μM concentration in 300 μL DMEM with
no FBS at pH 6.0 for 3 h. In experiment 11, the medium pH during treatment
was 7.4 instead of 6.0. In one set of experiments, the excess gold was re-
moved and 500 μL fresh DMEM at pH 7.4 with 10% FBS was added. In the
other set of experiments, the excess gold was not removed, and then 200 μL
fresh DMEM at pH 7.4 with 25% serum was added into wells to have 10% of
FBS in a final volume in the well. The treatment period was ∼3 h.
Cells were irradiated as described in the irradiation methods; control cells
accompanied the irradiated cells to and from the X-ray machine. Irradiated
cells were dissociated and combined for each treatment type, counted (using
a Coulter Counter Z1 instrument from Beckman Coulter for experiments 1–11
and an Auto T4 instrument from Nexcelom Bioscience for experiments 12–
17), and then reseeded in a six-well plate. Two hundred cells per well were
seeded for 0- and 1.5-Gray radiation doses, and 500 cells per well were
seeded for 3-Gray radiation dose. In general, six wells were seeded per
treatment type; the number of entries in SI Appendix, Table S2 is the
number of wells. A table entry with 12 values represents a treatment that
was done twice in the same experiment, with the results combined. After
∼10 d, each well was fixed and stained using a 2-mL mixture of 4% glu-
taraldehyde and 0.5% crystal violet in distilled water. Stained cell colonies
were hand-counted under a microscope. A colony was defined as a distinct
group of cells that contained 50 or more cells.
Fig. 3. Average cell survival after radiation and treatment (or no treatment,
control) with gold or gold-pHLIP at pH 6.0. The data shown in A are from the
experiments with either removal or nonremoval of excess gold before ra-
diation. The data shown in B are only from the experiments with non-
removal of excess gold before radiation. Error shown is SEM.
Table 1. Summary of ANOVA results for 1.5 Gray radiation
Model [normalized survival = treatment +
removal + (treatment · removal)] P values
No gold vs. gold-pHLIP 3.64 × 10−5
Gold-pHLIP vs. gold alone 0.015
No gold vs. gold alone 0.832
Removal vs. nonremoval 5.95 × 10−6
Detailed results are in SI Appendix, Table S6.
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Analysis of Cellular Uptake Data. The values in SI Appendix, Table S1 are six
readings from a mass spectrometer. P values for statistical significance were
computed using the t test, because the between-reading variance was much
greater than the error in each reading.
Analysis of Clonogenic Assay Data. To calculate statistical significance, the
data summarized in SI Appendix, Tables S2–S5 were analyzed using an
ANOVA, followed by a post hoc test using Tukey’s Honest Significant Dif-
ference. Each individual measurement from the clonogenic assay dish was
treated as a biological replicate and normalized to the average of the “0
Radiation, No Gold” measurements from the same experiment.
The linear model fitted for the ANOVA had three variables: normalized
survival (dependent variable), gold treatment (independent variable), and
removal/nonremoval of excess gold (independent variable). We left the
data for 0 radiation out of the analysis because normalizing by the “0
Radiation, No Gold” data points introduces a correlation if we use the
data by which we are normalizing. We analyzed the data for 1.5 Gray and
3 Gray separately because we were only really interested in the effect
at 1.5 Gray.
In the 1.5-Gray data, the interaction term between gold treatment and
removal/nonremoval was significant. This is consistent with the gold treat-
ments having different effectiveness depending onwhether or not the excess
gold was removed.
We also did one experiment at high pH, as mentioned in the Results. This
was analyzed with a separate analysis of variance. The data are included as
experiment 11 in SI Appendix, Tables S2, S3, and S5.
In Fig. 3, error shown is the SEM (41). SE was calculated using R, as SD
divided by square root of the number of samples. In checking the procedure
for this calculation, we used StatPlus, version v5 (AnalystSoft Inc.).
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